Navigating Financial and Health-Related Social Needs in Adolescent and Young Adult Cancer Survivors (AYA-NAV)
NCT06950983
Summary
Aim 1: Refine the HRSN navigation model to integrate a digital platform (Findhelp.org) to meet the needs of AYAs. The investigators will conduct iterative co-design sessions with AYAs and caregivers to understand their views on the existing Findhelp.org website and the likely need for other human-to-human and digital strategies to augment platform engagement (e.g., text reminders) and to address vocational needs. Aim 2: Evaluate the feasibility and acceptability of the refined hybrid intervention that includes digital + person-to-person HRSN navigation. Aim 3: Explore the preliminary impact of the refined hybrid intervention, compared to elevated usual care (a one-time referral to FindHelp.org alone), on reduction in financial distress (AYA and caregiver) and on AYA global health (i.e., mental, social, physical).
Eligibility
Inclusion Criteria: Aim 1: * AYAs (age 18-39) who have/had a diagnosis of cancer are eligible to participate. * English or Spanish-speaking Aim 2 and 3: * AYAs (age 15-39) who were diagnosed with cancer or began treatment for cancer within the past 6 months, or those who are still on first treatment for cancer (non-relapse) * English or Spanish-speaking * For AYAs who are \< 18 years, caregiver participation will be required; for AYAs \> 18 years, caregivers may co-participate if desired; the primary unit of focus is the AYA patient. Exclusion Criteria: * Dyad with caregiver or younger AYA that previously participated in study AAAU2405 or AAAY9477 * Unable to complete financial survey questions or contraindicated (as outlined in Protection of Human Subjects) * Dyad with younger AYAs who are enrolled on hospice or receiving other end-of-life care
Conditions2
Locations1 site
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
NCT06950983